Judith Waltz Quoted on Inflation Reduction Act, Pharma Impact

Foley & Lardner LLP partner Judith Waltz is quoted in the PharmaVoice article, “Pharmas’ IRA court losses mount. They keep pursuing them.”

“I expect that [pharmas] will continue to pursue litigation in multiple venues and with multiple theories,” said Waltz, who is co-chair of Foley’s Health Care Practice Group. “A particular court may see the underlying law and the agency’s efforts at implementation differently, and pharma companies could ‘get lucky’ in a particular court.  And if pharma can get a split in circuits, there may be a better shot at having an appeal to the Supreme Court accepted.

“Litigation might also delay the government’s process of implementation – even if a particular approach is not enjoined, it may give the government pause about moving forward with a particular angle,” Waltz added.